Market research
600518.SHG Kangmei Pharmaceutical Co., Ltd
SHG CNY Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 19B
- P/E ratio
- 0.0
- Analyst target
- 27.25
- Dividend yield
- Not available
- Beta
- 0.49
Community
Investor discussion
1 comment
Sign in to join the 600518.SHG discussion.
5 years, 5 months ago
Kangmei Pharmaceutical Co., Ltd is currently in a long term uptrend where the price is trading 14.4% above its 200 day moving average.
From a valuation standpoint, the stock is 77.2% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.2.
Kangmei Pharmaceutical Co., Ltd's total revenue sank by 34.3% to $1B since the same quarter in the previous year.
Its net income has dropped by 1711.1% to $-948M since the same quarter in the previous year.
Finally, its free cash flow fell by 57.9% to $420M since the same quarter in the previous year.
Based on the above factors, Kangmei Pharmaceutical Co., Ltd gets an overall score of 2/5.